• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

MDMA Therapy for PTSD Inches Closer to U.S. Approval

Results of a new study may offer regulators enough evidence to allow the psychedelic, also known as Ecstasy, to be considered for use as a PTSD treatment.

Rachel Nuwer
Author: Rachel Nuwer

Written by

Rachel Nuwer

in

Drug Enforcement Administration, Drugs (Pharmaceuticals), Ecstasy (Drug), Food and Drug Administration, MAPS Public Benefit Corporation, Post-Traumatic Stress Disorder, Psychiatry and Psychiatrists, Research, Therapy and Rehabilitation
←Spain’s Female Soccer Players Call Off Wage Dispute Strike
How Tim Flannery, the Giants Coach, Got Back to Writing Songs→

More posts

  • Fed Up With High Costs, American Theater Takes a Trip to London

  • Trump ‘willing to live with’ US report on missile strike on Iranian girls’ school

  • Rihanna’s Beverly Hills home hit by gunfire; suspect arrested, LAPD says

  • U.S. Solar Installations Fell in 2025 as Trump Attacked Clean Energy

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube